Skip to content

Sms-guided Training After Acute Stroke or Transient Ischemic Attack - a Randomized Controlled Trial

Effects of Sms-guided Outdoor Walking and Strength Training After Acute Stroke and TIA - a Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02902367
Acronym
SMS/TIA
Enrollment
80
Registered
2016-09-15
Start date
2016-11-30
Completion date
2018-10-31
Last updated
2017-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Stroke, TIA (Transient Ischemic Attack)

Keywords

mobility, exercise, walking capacity, fat mass, muscles

Brief summary

Eighty community-living individuals in Uppsala municipality will be included. Intervention: Outdoor walking exercise program and one strength exercise. Methods: Clinical assessments, questionnaires and medical records. Assessment of motor function, cognition, level of physical activity, food intake and perceived stress are performed at screening as baseline measurements. Walking capacity, mobility, handgrip strength, body composition and cardiovascular risk markers will be assessed at baseline and after 12 week of training. At one year after training health-related quality of life, another cardiovascular incidence and mortality will be documented.

Detailed description

Eighty community-living individuals in Uppsala municipality will be included in a randomized controlled trial with two arms. Intervention: Participants will perform an outdoor walking exercise program together with one strength exercise for 12 weeks. The intensity and frequency of the training will progressively increase. Participants are supposed to walk and perform strength training 5-7 days/week. Methods: Clinical assessments, questionnaires and medical records used for documentation of age, sex, comorbidity, blood pressure, medications and previous education. Assessment of motor function, cognition, level of physical activity, food intake and perceived stress are performed at screening as baseline measurements. Walking capacity (primary outcome measure), mobility, handgrip strength, body composition and cardiovascular risk markers will be assessed at baseline and after 12 week of training. At one year after training health-related quality of life, another cardiovascular incidence and mortality will be evaluated. Power analysis is performed. The investigators will analyze the data using an intention-to -treat analysis. Participants should have participated in at least 50% of the training sessions

Interventions

OTHEROutdoor walking and strength exercise

Exercise group: Participants are supposed to perform an outdoor walking exercise program and one strength exercise for 12 weeks. The first 2 weeks start with daily walks. The intensity and frequency of walks will progressively increase performed according to the Borg scale: 12-15, ie, moderate to strenuous. Participants will walk 5-7 days/week. Added to this is a strength exercise, i.e. chair-rising which also should be performed daily.

OTHERcontrol group

Control-Group: Treatment as usual for 12 weeks, without restriction of being physically active.

Sponsors

Uppsala County Council, Sweden
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Verified ischemic cerebral infarction or intracerebral hemorrhage. 2. Sufficient walking capacity and motor function 3. Able to communicate in Swedish 4. Signed consent

Exclusion criteria

One or more of the following: 1. Subarachnoid bleeding 2. Insufficient cognition and impaired ability to understand instructions 3. Medical problems that make it unsuitable to participate 4. Pacemaker (body composition measurements)

Design outcomes

Primary

MeasureTime frameDescription
6 minute walk test (6MWT)from baseline walking capacity to three monthswalking capacity

Secondary

MeasureTime frameDescription
10 meter walk test (10mWT)from baseline 10mWT to three monthsgait speed
Hand-dynamometer (Jamar)from baseline Jamar to three monthshand-grip strength
Body composition (bioelectric impedance analysis)from baseline body composition to three monthsmuscles and fat mass and BMI
Cardiometabolic risk markersfrom baseline cardiometabolic risk markers to three monthsblood lipids, c-reactive proteins (CRP), blood glukos, HbA1c, Insulin-like growth factor (IGF-1), Interleukin-6 (Il-6)
Heart and lung foundation stress testat baselineself-perceived stress
Short Physical Performance Battery (SPPB)from baseline SPPB to three monthsmobility
Montreal outcome assessment (MoCA)at baselinecognition
Modified rankin scale (MRS)at baselinemotor function
Mortalityfrom baseline to 1 yearregister-based mortality
Health-related quality of lifefrom baseline to 1 yearregister-based quality of life
Food frequency questionnaireat baselineself-reported food intake and quality

Countries

Sweden

Contacts

Primary ContactBirgit Vahlberg, Med Dr, RPT
birgit.vahlberg@pubcare.uu.se+46709583473
Backup ContactTommy Cederholm, Professor,MD
tommy.cederholm@pubcare.uu.se+46702733192

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026